Background: Stroke volume (SV) and aortic valve area calculations require the left ventricular (LV) outflow tract (LVOT) or aortic annular area calculations that involve squaring the respective diameters. Area calculation errors became evident with transcatheter aortic valve replacement where areas were underestimated due to an elliptical annulus. We hypothesized that LVOT and annular shape are more elliptical in patients with greater relative LV wall thickness (RWT) leading to underestimation of SV index using 2D Doppler echocardiography. Methods: We studied 203 consecutive patients referred to an outpatient noninvasive laboratory for Doppler echocardiograms which included acceptable 3-dimensional images. 3-dimensional assessment of the LVOT at 3–5 mm from the valve insertion, at the site of valve insertion, and at the sinus of Valsalva (SOV) was performed with assessment of the minor axis (MN), major axis (MJ), and areas at mid-systole. SV index was calculated from LVOT and annular diameters obtained from 2-dimensional echo and from 3-dimensional LVOT areas. Results: An inverse relation of RWT with MN/MJ at mid-systole for the LVOT (r = 0.5812, P < 0.0001) and annulus (r = 0.6865, P < 0.0001) was noted. LVOT and annulus areas were similar among groups at mid-systole. SV index calculated from 2D LVOT dimensions was significantly smaller than using 3D LVOT areas (35.6 ± 8.9 vs 53.6 ± 16.1 mL, P < 0.0001). Conclusion: There is an inverse relation between MN/MJ and RWT at the LVOT and aortic annulus despite the LVOT and annular areas being similar across most geometries resulting in SV index underestimation calculated using LVOT diameters vs 3D LVOT areas.

京都大学 / 0048 / 新制・論文博士 / 博士(医学) / 乙第13380号 / 論医博第2214号 / 新制||医||1047(附属図書館) / 京都大学大学院医学研究科外科系専攻 / (主査)教授 山下 潤, 教授 木村 剛, 教授 浅野 雅秀 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM

Background: Chronic aortic regurgitation (AR) patients demonstrate left ventricular (LV) remodeling with increased LV mass and volume but may have a preserved LV ejection fraction (EF). We hypothesize that in chronic AR, global longitudinal systolic and diastolic function will be reduced despite a preserved LV EF. Methods: We studied with Doppler echocardiography 27 normal subjects, 87 patients with chronic AR with a LV EF > 50% (AR + PEF), 66 patients with an EF < 50% [AR + reduced LV ejection fraction (REF)] and 82 patients with hypertensive heart disease. LV volume, transmitral spectral and tissue Doppler were obtained. Myocardial velocities and their timing and longitudinal strain of the proximal and mid wall of each of the 3 apical views were obtained. Results: As compared to normals, global longitudinal strain was reduced in AR + PEF (13.8 ± 4.0%) and AR + REF (11.4 ±4.7%) vs. normals (18.4 ± 3.6%, both p < 0.001). As an additional comparison group for AR + PEF, global longitudinal strain was reduced as compared to patients with hypertensive heart disease (p = 0.032). The average peak diastolic annular velocity (e’) was decreased in AR + PEF (6.9 ± 3.3 cm/s vs. 13.4 ± 2.6 cm/s, p < 0.001) and AR + REF (4.8 ± 2.1 cm/s, p < 0.001). Peak rapid filling velocity/e’ (E/e’) was increased in both AR + PEF (14.4 ± 6.2 vs. 6.2 ± 1.3, p < 0.001) and AR + REF (18.8 ± 6.4, p <0.001 vs. normals). Independent correlates of global longitudinal strain (r = 0.6416, p < 0.001) included EF (p < 0.0001), E/e’ (p < 0.0001), and tricuspid regurgitation velocity (p = 0.0176). Conclusion: With chronic AR, there is impaired longitudinal function despite preserved EF. Moreover, global longitudinal strain was well correlated with noninvasive estimated LV filling pressures and pulmonary systolic arterial pressures.

Coronary artery disease remains the leading cause of death in the United States with over 1 million acute coronary events predicted to take place in 2019 alone. Heart failure, a common and deadly sequela of myocardial infarction (MI), is attributed to adverse ventricular remodeling driven by cardiomyocyte death, inflammation, and mechanical factors. Despite strong evidence suggesting the importance of myocardial mechanics in driving cardiac remodeling, many <i>in vivo</i> MI studies still rely on 2D analyses to estimate global left ventricular (LV) function and approximate strain using a linear definition. These metrics, while valuable in evaluating the overall impact of ischemic injury on cardiac health, do not capture regional differences in myocardial contractility. The objective of this work is therefore to expand upon existing ultrasound studies by enabling regional analysis of 3D myocardial strain. By integrating our recently developed four-dimensional ultrasound (4DUS) imaging technique with a direct deformation estimation algorithm for 3D strain, we identified unique remodeling patterns and regional strain differences between two murine models of MI with different infarct severities. By constructing 3D strain maps of the remodeling LVs, we were able to capture strain heterogeneity and characterize a sigmoidal strain profile at infarct border zones. Finally, we demonstrated that the maximum principal component of the 3D Green-Lagrange strain tensor correlates with LV remodeling severity and is predictive of final infarct size. Taken together, the presented work provides a novel and thorough approach to quantify regional 3D strain, an important component when assessing post-MI remodeling.

Remarkable advances have been made in the treatment of cardiovascular diseases (CVD), however, CVD still accounts for the most deaths in industrialized nations. Ischemic heart disease (IHD) can lead to acute coronary syndrome (ACS) (myocardial infarction [MI]). The standard of care is reperfusion therapy followed by pharmacological intervention to attenuate clinical symptoms related to the MI. While survival from MI has dramatically increased with the implementation of reperfusion therapy, these individuals will inevitably suffer progressive pathological remodeling leaving them predispose to develop heart failure (HF). HF is a clinical syndrome defined as the impairment of the heart to maintain organ perfusion at rest and/or during times of exertion (i.e. exercise intolerance). Clinically, this is accompanied by dyspnea, pulmonary or splanchnic congestion and peripheral edema. Physiologically, there is neurohormal activation through the classical β–adrenergic and PKA–dependent signalin / Physiology

L’infarctus du myocarde (IDM), responsable du remodelage ventriculaire, peut conduire, s’il est délétère, à l’insuffisance cardiaque (IC), principale cause de mortalité à travers le monde. Les récentes découvertes ont montré l’implication des ARNs non codants, microARNs (miARNs) et les longs ARNs non codants (lncARNs), dans les processus physiologiques et pathologiques et notamment dans les maladies cardiovasculaires. L’objectif de ce travail a été d’étudier le potentiel des miARNs et des lncARNs en tant que biomarqueurs pronostiques et diagnostiques ainsi qu’en tant que cibles thérapeutiques dans l’IDM et le remodelage ventriculaire. Dans un premier temps, nous avons évalué le pouvoir diagnostique des miARNs sur une cohorte de patients présentant des douleurs thoraciques. Le miR-208b et le miR-499 ont montré une bonne capacité diagnostique de l’IDM, ne dépassant toutefois pas celle des troponines. Nous avons ensuite observé que le miR-150 présente une plus faible concentration dans le sang de patients avec un remodelage ventriculaire post-IDM par rapport aux patients sans remodelage, le positionnant comme un biomarqueur intéressant dans le pronostic de l’IC. Enfin, nous avons montré une régulation importante de plusieurs lncARNs dans le cœur de souris, 24 heures après IDM et 2 lncARNs, MIRT1 et MIRT2, ont été mis en avant pour leur association avec le remodelage. En conclusion, nos études ont montré l’utilité des ARNs non codants pour améliorer l’identification des patients à risque de développer une IC après IDM et ont permis également de mettre en évidence de nouvelles cibles thérapeutiques qui pourraient prévenir le remodelage ventriculaire post-IDM / Myocardial infarction (MI responsible for left ventricular remodeling which can be deleterious and the development of heart failure (HF). HF is one of the leading causes of mortality worldwide and despite many improvements, it remains a major challenge in clinical practice. Recent discoveries in genomics have showed the involvement of non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), in physiological and pathological processes and notably linked to cardiovascular diseases. The goal of this work was to study the potential of miRNAs and lncRNAs as prognostic and diagnostic biomarkers and as therapeutic targets in MI and left ventricular remodeling leading to HF. First, we evaluated the diagnostic value of miRNAs in patients with chest pain. MiRNA-208b and miR-499 have shown a good diagnostic capacity for MI. However, these miARNs failed to improve the diagnosis of MI by troponins. MiRNA-208b could also predict patient mortality after MI but this capacity was modest. Then, we observed that miR-150 was present at a low level in the blood of patients with left ventricular remodeling post-MI compared to patients without remodeling. Therefore, miRNA-150 is an interesting prognostic biomarker. Finally, we have shown a significant regulation of several lncRNAs in mouse heart, 24 hours after MI, and 2 lncRNAs, MIRT1 and MIRT2, have been demonstrated for their association with left ventricular remodeling. In conclusion, our studies have shown the utility of non-coding RNAs to improve the identification of patients at risk of developing HF after MI and also allowed to identify potential therapeutic targets to prevent left ventricular remodeling

Le remodelage ventriculaire est un processus réactionnel pouvant faire suite à un infarctus du myocarde (IDM), évènement ischémique aigu survenant lors de l'obstruction d'une artère coronaire. Le remodelage provoque alors des changements géométriques et fonctionnels du tissu myocardique qui permettent de maintenir et d'adapter la fonction cardiaque. Lorsque ce processus est délétère, la maladie évolue vers l'insuffisance cardiaque, ce qui altère le pronostic et la qualité de vie des patients. L'adénosine est un nucléoside ubiquitaire dont les effets sur le remodelage ventriculaire après IDM sont encore peu connus et dépendent du type de récepteur activé. Au sein de notre laboratoire, de précédentes études in vitro ont montré que l'adénosine régule de nombreux acteurs clés du remodelage. Dans ce travail de thèse, nous avons émis l'hypothèse que l'adénosine pouvait avoir un effet bénéfique sur le remodelage ventriculaire après la survenue d'un IDM. Dans un premier temps, nous avons montré que la tomographie par émission de positrons (TEP) permet de caractériser précisément les séquelles d'IDM et de prédire le remodelage ventriculaire chez le rat après occlusion coronaire. Cette technique nous a permis de mettre en évidence le cas d'un rat ayant survécu à un IDM touchant plus de 70% de son ventricule gauche. Dans un deuxième temps, nous avons montré que l'administration chronique d'adénosine, à long terme après IDM chez le rat, permet de maintenir la contractilité cardiaque dans la zone bordant l'IDM. Cet effet cardioprotecteur peut s'expliquer par une stimulation de l'angiogenèse elle-même due à un recrutement de cellules endothéliales progénitrices circulantes. Ensuite, nous avons montré que la chimiokine Monocyte Chemotactic Protein 3 est capable de stimuler la migration des cellules endothéliales progénitrices et est ainsi un agent thérapeutique potentiel après IDM. Enfin, nous avons commencé l'étude préclinique d'une molécule agoniste du récepteur A2A à l'adénosine et antagoniste du récepteur A3, un candidat particulièrement prometteur pour prévenir le remodelage ventriculaire après IDM / Left ventricular (LV) remodeling can follow myocardial infarction (MI), an acute ischemic event which occurs after occlusion of a coronary artery. Remodeling allows maintaining and adapting cardiac function by geometric and functional changes of the myocardium. If this process becomes maladaptive, the patients? prognostic and life quality are impaired by the development of heart failure. Adenosine is an ubiquitous nucleoside with partially characterized effects on LV remodeling. These effects depend on the type of receptor activated. Previous in vitro studies from our laboratory have shown that adenosine regulates several key processes involved in LV remodeling. Here, we hypothesized that adenosine may have beneficial effects on LV remodeling after MI. First, we showed that positon emission tomography (PET) can accurately characterize MI severity and predicts subsequent LV remodeling in the rat model of MI induced by coronary occlusion. Using this technique, we described the case of a rat that survived after a massive infarct covering 70% of the left ventricle. Second, we showed that a chronic administration of adenosine preserves cardiac contractility in the border zone, two months after MI. This cardioprotective effect can be explained, in part, by the stimulation of angiogenesis involving a stimulation of the recruitment of endothelial progenitor cells to the heart. Then, we showed that the Monocyte Chemotactic Protein 3 stimulates the migration of endothelial progenitor cells and is thereby a potential therapeutic target after MI. Finally, we started the preclinical study of an A2A agonist / A3 antagonist, a promising candidate to prevent LV remodeling after MI

Made available in DSpace on 2016-06-02T19:22:57Z (GMT). No. of bitstreams: 1 5061.pdf: 12379581 bytes, checksum: c5740c3bf0a93d60530d4f55769c222d (MD5) Previous issue date: 2013-03-22 / Universidade Federal de Sao Carlos / Obesity is associated with increased lipid peroxidation in the myocardium and an increased susceptibility to oxidative damage, which can lead to several cardiovascular risk factors including heart failure, insulin resistance, hypertension and dyslipidemia. The ONOOin conjunction with normal intracellular levels of reduced glutathione (GSH), are responsible, among other factors, to activate the matrix metalloproteinases (MMPs) that are important in mediating the deleterious effects of cardiovascular diseases. The unregulated activity of MMPs, such as MMP-2, may promote the development of heart disease. Resistance training (RT) can mitigate or even reverse the obesity, prevent against lipid peroxidation, increasing the levels of antioxidant enzymes, improved lipid profile, reduced cardiovascular risk and reduce the concentration of fibrosis and dysregulation of MMP-2. Purpose: To analyze the effects of RT high intensity on ladder associated with high fat diet on the activity of MMP-2 and antioxidant enzymes (SOD Total, Mn-SOD, CAT, GPx), GSH and lipid peroxidation, related to left ventricle remodeling in rats. Methods: 60 rats Wistar were used in this study, which was divided into three phases: 1) three week period of obesity induction, control group fed with standard diet (CT-S n = 30) and control group fed with high fat diet (CT-H n = 30); 2) effect of fat diet for eight weeks, sedentary standard diet group (SED-S n = 10) and high fat diet sedentary (SED-H n = 10), 3) effect of high-intensity RT on ladder for eight weeks associated with high-fat diet, RT standard diet (RT-S n = 10) and RT high-fat diet RT (RT-H n = 10). Results: The three-week obesity induction was effective in promoting the group CTH increased body mass (p <0.05), LV mass (p <0.05) and activity of MMP-2 (p <.001), TBRs (p <0.03) and decrease the citrate synthase activity (p <0.05). After eight weeks of high fat diet, the SED-H group had a higher body mass (p <0.02) compared to SED-S. The volume LV for SED-H group was higher compared to that of CT-H (p <0.001), but did not change when compared to SED-S. There was a lower activity of MMP-2 (p <0.05) in SED-S compared to CT-H. Lipid accumulation was observed (p <0.007) in the LV of SED-H group compared to CT-H. The longer life associated with high-fat diet promoted suppression in the enzymatic activity of SOD Total (p <0.01) and Mn-SOD (p <0.002) (SED-H), and increased activity of GSH (p <0.004). The RT was effective in attenuating the gain body mass in RT-H group compared to SED-H, even though higher compared to RT-S (p <0.005). In the group RT-H of MMP-2 activity was higher (p <0.03) compared to RT-S, but lower (p <0.04) compared to SED-H. The RT promoted greater citrate synthase activity (p <0.03), SOD Total (p <0.001) and Mn-SOD (p <0.03) and lower activity of GSH (p <0.01) in RT-H. There was no significant increase in TBARs level in the VE of the RT-H group. However, we observed increased lipid content (p <0.04). Conclusion: We conclude that high intensity RT, in obese rats, could be a pharmacological tool able to positively modulate the activity of MMP-2 and some antioxidant enzymes such as SOD Total, Mn-SOD and GSH. These effects are important for the maintenance of heart health, relieving the deleterious effects on obesityrelated of the left ventricle remodeling, so experiment. / A obesidade está associada com aumento da peroxidação lipídica no miocárdio e com uma maior suscetibilidade ao dano oxidativo, o que pode levar a vários fatores de risco cardiovascular incluindo insuficiência cardíaca, resistência à insulina, hipertensão e dislipidemia. O ONOO- em conjunto com níveis normais intracelular de glutationa reduzida (GSH), são responsáveis, dentre outros fatores, por ativar as metaloproteinases de matriz (MMPs), que são importantes na mediação dos efeitos deletérios de doenças cardiovasculares. A atividade desregulada das MMPs, como a MMP-2, pode favorecer o desenvolvimento de doenças cardíacas. O treinamento resistido (TR) pode amenizar ou mesmo reverter o quadro de obesidade, prevenir contra a peroxidação lipídica, aumentando os níveis das enzimas antioxidantes, melhora do perfil lipídico, diminui os riscos á doenças cardiovasculares, além de reduzir a concentração de fibrose e a desregulação da MMP-2. Objetivo: Analisar os efeitos do TR de alta intensidade em escada associado à dieta hiperlipídica na atividade da MMP-2 e enzimas antioxidantes (SOD Total, Mn-SOD, CAT, GPx), GSH e peroxidação lipídica, relacionadas ao remodelamento do ventrículo esquerdo, em ratos. Metodologia: 60 ratos Wistar foram utilizados neste estudo, sendo este divido em três fases: 1) período de três semanas de indução à obesidade, grupo controle alimentado com dieta padrão (CT-P n= 30) e controle alimentado com dieta hiperlipídica (CT-H n= 30); 2) efeito da dieta hiperlipídica por mais oito semanas, grupo sedentário dieta padrão (SED-P n= 10) e sedentário dieta hiperlipídica (SED-H n= 10); 3) efeito do TR em escada por oito semanas associado a dieta hiperlipídica, grupo TR dieta padrão (TR-P n= 10) e TR dieta hiperlipídica (TR-H n= 10). Resultados: As três semanas de indução à obesidade foi eficaz em promover aumento da massa corporal (p < 0,05), massa do VE (p < 0,05) e da atividade da MMP-2 (p < 0,001), do TBRs (p < 0,03) e de diminuir a atividade da citrato sintase (p < 0,05) no grupo CT-H. Após mais oito semanas de dieta hiperlipídica, o grupo SED-H teve a massa corporal maior (p < 0,02) comparado ao SED-P. Já a massa do VE para o grupo SED-H foi maior em comparação ao do CT-H (p < 0,001), porém não se modificou quando comparado ao SEP-P. Houve uma menor atividade da MMP-2 (p < 0,05) no grupo SED-H comparado ao CT-H. Foi observado acúmulo de lipídios totais (p < 0,007) no VE do grupo SD-H comparado ao CT-H. O maior tempo de vida associado à dieta hiperlipídica promoveu inibição da SOD Total (p < 0,01) e Mn-SOD (p < 0,002) (SED-H), e aumento da GSH (p < 0,004). O TR foi eficaz em atenuar o ganho de massa corporal no grupo TR-H comparado ao SED-H, mesmo sendo maior comparado ao TR-P (p < 0,005). No grupo TR-H a atividade da MMP-2 foi maior (p < 0,03) comparado ao TR-P, porém menor (p < 0,04) comparado ao SED-H. O TR promoveu maior atividade das enzimas citrato sintase (p < 0,03), SOD Total (p < 0,001) e Mn-SOD (p < 0,03) menor atividade da GSH (p < 0,01) no grupo TR-H. Não foi observado aumento significativo do TBARS no VE do TR-H. Contudo, foi observado aumento do conteúdo lipídico (p < 0,04). Conclusão: Concluímos que o TR de alta intensidade, em ratos obesos, pode ser uma ferramenta não farmacológica capaz de modular de forma positiva a atividade da MMP-2 e de algumas enzimas antioxidantes como a SOD Total, Mn-SOD e a GSH. Efeitos esses que são importantes para a manutenção da saúde cardíaca, amenizando os efeitos deletérios relacionados à obesidade sobre o remodelamento do ventrículo esquerdo, de forma experimental.